Cancer Res Treat.  2004 Dec;36(6):341-342.

Preoperative Concurrent Chemoradiotherapy with Oral Fluoropyrimidine in Locally Advanced Rectal Cancer: How Good Is Good Enough?

• Chung HC

Abstract

No abstract available.

MeSH Terms

Chemoradiotherapy*
Rectal Neoplasms*

Reference

1. Park J, Kim JH, Ahn SD, Lee S, Shin SS, Kim JC, et al. Prospective phase II study of preoperative chemoradiation with capecitabine in locally advanced rectal cancer. Cancer Res Treat. 2004; 36:354–359.

2. Sauer R. German Rectal Cancer Group. Adjuvant versus neoadjuvant combined modality treatment for locally advanced rectal cancer. First result of the German Rectal Cancer Study (CAO/ARO/AIO-94). Int J Radiat Oncol Biol Phys. 2003; 57(supple 2):S124–S125. PMID: 14535238.

3. Dunst J, Reese T, Sutter T, Zuhlke H, Hinke A, Kolling-Schlebusch K, et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol. 2002; 20:3983–3991. PMID: 12351595.

4. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, et al. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: The Lyon R0-04 phase II trial. J Clin Oncol. 2003; 21:1119–1124. PMID: 12637479.

5. Uzcudun AE, Batlle JF, Velasco JC, Sanchez Santos ME, Carpeno Jde C, Grande AG, et al. Efficacy of preoperative radiation therapy for respectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: result from a phase II study. Dis Colon Rectum. 2002; 45:1349–1358. PMID: 12394434.

6. Rich TA, Skibber JM, Ajani JA, Buchholz DJ, Cleary KR, Dubrow RA, et al. Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys. 1995; 32:1025–1029. PMID: 7607922.

7. Meterissian S, Skibber J, Rich T, Roubein L, Ajani J, Cleary K, et al. Patterns of residual disease after preoperative chemoradiation in ultrasound T3 rectal carcinoma. Ann Surg Oncol. 1994; 1:111–116. PMID: 7834435.

8. Janjan NA, Abbruzzese J, Pazdur R, Khoo VS, Cleary K, Dubrow R, et al. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol. 1999; 51:153–160. PMID: 10435807.

9. MacFarlane JK, Ryall R, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993; 341:457–460. PMID: 8094488.

10. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345:638–646. PMID: 11547717.

11. Mohiuddin M, Regine WF, John WJ, Hagihara PF, McGrath PC, Kenady DE, et al. Preoperative chemoradiation in fixed distal rectal cancer: dose time factors for pathological complete response. Int J Radiat Oncol Biol Phys. 2000; 46:883–888. PMID: 10705009.

12. Crane CH, Ellis L, Xiong H. Preliminary results of a phase I study of rhuMab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine. In : ASCO GI Symposium; January 2004; San Francisco, CA. –abstr 85.